APAC / Diagnostics in the Post-COVID Era
COVID-19 has pushed diagnostics to the forefront of healthcare conversations across the world. Here, three leading lights from the Asia-Pacific medtech industry weigh in on what the new diagnostics paradigm…
APAC / The Challenges of Regulatory Convergence in Medtech
Regulatory harmonisation for medical devices between countries in Asia-Pacific has long been a challenging issue, predominantly due to the extreme variation in cultures, economic development, governmental models, and healthcare systems…
Singapore / Finding the Right Pharma Talent Post-COVID
Singapore – despite its modest USD 1.22 billion domestic market – has long been one of Asia’s leading biopharmaceutical hubs and a magnet for top talent. Multitudes of biopharma and…
Asia-Pacific / HSA: A Regulatory Gold Standard for the Region
As the most important pharma hub in its region, and one of the most important globally, many companies look to launch new products in Singapore first before expanding to other…
APAC / Medtech's Post-COVID Paradigm
At USD 150 billion, Asia-Pacific is home to the world’s second largest medtech market and, with a CAGR of nine percent, certainly its most dynamic. Chronic underfunding of healthcare systems…
APAC / Singapore Pharma Exports Rise as Global API Demand Surges
The ongoing COVID-19 pandemic is a double-edged sword for Singapore. While its economy has been hit by the global crisis, the island city-state is seeing an uptick in pharmaceutical manufacturing…
News Roundup / Asia-Pacific Pharma June 2020
A roundup of some of the most significant healthcare and life science stories from across Singapore and the Asia-Pacific region, including the ongoing hunt for a COVID-19 vaccine and a…
Beyond the Pill — Pharma Takes a Stake In Digital Health
Rhenu Bhuller, a founding member of Frost & Sullivan’s Asia Pacific operations and expert in analysing the impact of cutting-edge tech, looks at pharma’s evolution and adoption of digital health.…
Diversity, Inclusion and Addressing Unconscious Bias
Ai Hua Ong, Company Group Chairman, Asia Pacific, The Janssen Pharmaceutical Companies of Johnson & Johnson. There is a clear correlation between an inclusive culture and innovation Creating a…
Singaporean Logistics: Taking Pharma to New Heights
Singapore’s location at the heart of the APAC region, expertise in logistics and cold chain management, and smart investment in infrastructure has helped make the Lion City an indisputable global…
Asia-Pacific Healthcare: Managing Diversity
The Asia-Pacific region is a vast geographic area, home to almost half of the world’s population and numerous emerging and developed markets with great investment potential for healthcare and life…
Singapore’s Recipe for Success
Singapore, though conscious of its limitations, has been able to leverage its key assets of location, infrastructure and local talent in order to become the business hub for the entire…